Moody National Bank Trust Division’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.98M Buy
15,834
+173
+1% +$37.2K 0.33% 52
2026
Q1
$3.41M Buy
15,661
+113
+0.7% +$25.1K 0.32% 44
2025
Q4
$3.55M Sell
15,548
-5,674
-27% -$1.29M 0.34% 48
2025
Q3
$4.91M Sell
21,222
-1,090
-5% -$222K 0.41% 45
2025
Q2
$4.14M Sell
22,312
-791
-3% -$147K 0.38% 51
2025
Q1
$4.84M Buy
23,103
+586
+3% +$114K 0.5% 40
2024
Q4
$4M Sell
22,517
-951
-4% -$175K 0.42% 41
2024
Q3
$4.63M Buy
23,468
+3,990
+20% +$745K 0.5% 38
2024
Q2
$3.34M Buy
19,478
+5
+0% +$828 0.26% 41
2024
Q1
$3.55M Buy
19,473
+1,480
+8% +$255K 0.28% 35
2023
Q4
$2.79M Sell
17,993
-21,961
-55% -$3.2M 0.22% 58
2023
Q3
$5.96M Buy
39,954
+4,697
+13% +$690K 0.38% 33
2023
Q2
$4.75M Sell
35,257
-39
-0.1% -$5.72K 0.33% 39
2023
Q1
$5.63M Buy
35,296
+2
+0% +$306 0.48% 33
2022
Q4
$5.7M Buy
35,294
+873
+3% +$134K 0.5% 29
2022
Q3
$4.62M Buy
34,421
+2,908
+9% +$417K 0.48% 34
2022
Q2
$4.83M Sell
31,513
-4,210
-12% -$643K 0.51% 29
2022
Q1
$5.79M Sell
35,723
-5,945
-14% -$864K 0.18% 25
2021
Q4
$5.64M Sell
41,668
-118,823
-74% -$14M 0.17% 35
2021
Q3
$17.3M Sell
160,491
-116
-0.1% -$13.3K 0.25% 39
2021
Q2
$18.1M Sell
160,607
-1,114
-0.7% -$125K 0.37% 34
2021
Q1
$17.5M Sell
161,721
-63
-0% -$6.74K 0.42% 32
2020
Q4
$17.3M Buy
161,784
+1,461
+0.9% +$140K 0.44% 35
2020
Q3
$14M Buy
160,323
+303
+0.2% +$28.5K 0.43% 45
2020
Q2
$15.7M Buy
160,020
+26,846
+20% +$2.36M 0.49% 32
2020
Q1
$10.1M Buy
133,174
+446
+0.3% +$38K 0.36% 49
2019
Q4
$11.8M Buy
132,728
+2,610
+2% +$217K 0.31% 55
2019
Q3
$9.85M Sell
130,118
-764
-0.6% -$52.4K 0.28% 61
2019
Q2
$9.52M Sell
130,882
-201
-0.2% -$15.8K 0.27% 62
2019
Q1
$10.6M Sell
131,083
-483
-0.4% -$39.5K 0.29% 56
2018
Q4
$12.1M Buy
131,566
+968
+0.7% +$85.1K 0.34% 40
2018
Q3
$12.4M Buy
130,598
+120,040
+1,137% +$11.4M 0.31% 50
2018
Q2
$978K Sell
10,558
-375
-3% -$36.6K 0.05% 73
2018
Q1
$1.03M Sell
10,933
-525
-5% -$57.7K 0.05% 68
2017
Q4
$1.11M Sell
11,458
-50
-0.4% -$4.71K 0.05% 63
2017
Q3
$1.02M Sell
11,508
-1,700
-13% -$129K 0.05% 67
2017
Q2
$958K Hold
13,208
0.05% 91
2017
Q1
$860K Sell
13,208
-630
-5% -$39.6K 0.04% 99
2016
Q4
$867K Hold
13,838
0.04% 90
2016
Q3
$872K Sell
13,838
-745
-5% -$48.2K 0.05% 88
2016
Q2
$903K Buy
14,583
+40
+0.3% +$2.44K 0.05% 81
2016
Q1
$831K Buy
14,543
+520
+4% +$29K 0.05% 83
2015
Q4
$831K Sell
14,023
-2,000
-12% -$115K 0.06% 75
2015
Q3
$872K Buy
16,023
+65
+0.4% +$4.23K 0.07% 70
2015
Q2
$1.07M Hold
15,958
0.08% 59
2015
Q1
$934K Buy
15,958
+157
+1% +$9.48K 0.07% 69
2014
Q4
$1.03M Sell
15,801
-7,459
-32% -$470K 0.07% 74
2014
Q3
$1.34M Buy
23,260
+8,105
+53% +$450K 0.09% 48
2014
Q2
$856K Hold
15,155
0.06% 85
2014
Q1
$779K Hold
15,155
0.05% 87
2013
Q4
$801K Sell
15,155
-70
-0.5% -$3.44K 0.05% 84
2013
Q3
$681K Sell
15,225
-795
-5% -$35.2K 0.05% 98
2013
Q2
$662K Buy
+16,020
New +$701K 0.05% 91

Other funds holding ABBV

Moody National Bank Trust Division's ABBV Position: Q2 2026 in Review

Moody National Bank Trust Division increased its AbbVie (ABBV) stake by 1.1% in Q2 2026, buying an estimated $37.2K and bringing the position to 15,834 shares worth $3.98M. The position accounts for 0.33% of the portfolio, ranked #52.

Moody National Bank Trust Division first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $18.1M in Q2 2021. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Moody National Bank Trust Division held 15,834 shares of AbbVie worth $3.98M as of Q2 2026.
  • Moody National Bank Trust Division bought 173 AbbVie shares in Q2 2026, an estimated $37.2K.
  • AbbVie made up 0.33% of Moody National Bank Trust Division's portfolio in Q2 2026, its #52 holding.
  • Moody National Bank Trust Division first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
  • Moody National Bank Trust Division's AbbVie position peaked at $18.1M in Q2 2021.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Moody National Bank Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.